Shattuck Labs (STTK) Competitors $2.14 +0.35 (+19.55%) Closing price 04:00 PM EasternExtended Trading$2.17 +0.03 (+1.64%) As of 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock STTK vs. SCPH, GALT, TVRD, NGNE, LFCR, MREO, ACB, RNAC, CADL, and MNPRShould you be buying Shattuck Labs stock or one of its competitors? The main competitors of Shattuck Labs include scPharmaceuticals (SCPH), Galectin Therapeutics (GALT), Tvardi Therapeutics (TVRD), Neurogene (NGNE), Lifecore Biomedical (LFCR), Mereo BioPharma Group (MREO), Aurora Cannabis (ACB), Cartesian Therapeutics (RNAC), Candel Therapeutics (CADL), and Monopar Therapeutics (MNPR). These companies are all part of the "pharmaceutical products" industry. Shattuck Labs vs. Its Competitors scPharmaceuticals Galectin Therapeutics Tvardi Therapeutics Neurogene Lifecore Biomedical Mereo BioPharma Group Aurora Cannabis Cartesian Therapeutics Candel Therapeutics Monopar Therapeutics scPharmaceuticals (NASDAQ:SCPH) and Shattuck Labs (NASDAQ:STTK) are both small-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their earnings, valuation, dividends, profitability, risk, analyst recommendations, institutional ownership and media sentiment. Is SCPH or STTK more profitable? Shattuck Labs has a net margin of 0.00% compared to scPharmaceuticals' net margin of -183.55%. Shattuck Labs' return on equity of -81.80% beat scPharmaceuticals' return on equity.Company Net Margins Return on Equity Return on Assets scPharmaceuticals-183.55% -1,647.86% -71.76% Shattuck Labs N/A -81.80%-71.46% Do analysts rate SCPH or STTK? scPharmaceuticals currently has a consensus price target of $7.78, indicating a potential upside of 38.49%. Shattuck Labs has a consensus price target of $4.00, indicating a potential upside of 86.92%. Given Shattuck Labs' stronger consensus rating and higher probable upside, analysts clearly believe Shattuck Labs is more favorable than scPharmaceuticals.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score scPharmaceuticals 0 Sell rating(s) 3 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00Shattuck Labs 0 Sell rating(s) 3 Hold rating(s) 2 Buy rating(s) 2 Strong Buy rating(s) 2.86 Do institutionals & insiders have more ownership in SCPH or STTK? 89.5% of scPharmaceuticals shares are owned by institutional investors. Comparatively, 58.7% of Shattuck Labs shares are owned by institutional investors. 4.8% of scPharmaceuticals shares are owned by company insiders. Comparatively, 12.0% of Shattuck Labs shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth. Does the media refer more to SCPH or STTK? In the previous week, Shattuck Labs had 16 more articles in the media than scPharmaceuticals. MarketBeat recorded 21 mentions for Shattuck Labs and 5 mentions for scPharmaceuticals. scPharmaceuticals' average media sentiment score of 1.34 beat Shattuck Labs' score of 0.95 indicating that scPharmaceuticals is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment scPharmaceuticals 2 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Shattuck Labs 2 Very Positive mention(s) 2 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Which has higher earnings and valuation, SCPH or STTK? Shattuck Labs has lower revenue, but higher earnings than scPharmaceuticals. scPharmaceuticals is trading at a lower price-to-earnings ratio than Shattuck Labs, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioscPharmaceuticals$36.33M8.25-$85.15M-$1.81-3.10Shattuck Labs$5.72M17.92-$75.41M-$1.21-1.77 Which has more volatility & risk, SCPH or STTK? scPharmaceuticals has a beta of 0.35, meaning that its stock price is 65% less volatile than the S&P 500. Comparatively, Shattuck Labs has a beta of 1.64, meaning that its stock price is 64% more volatile than the S&P 500. SummaryShattuck Labs beats scPharmaceuticals on 14 of the 17 factors compared between the two stocks. Get Shattuck Labs News Delivered to You Automatically Sign up to receive the latest news and ratings for STTK and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding STTK and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart STTK vs. The Competition Export to ExcelMetricShattuck LabsMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$85.75M$3.12B$5.73B$10.31BDividend YieldN/A2.36%5.90%4.63%P/E Ratio-1.7721.1675.8626.51Price / Sales17.92446.35528.74123.58Price / CashN/A45.4037.1760.46Price / Book1.289.6212.796.29Net Income-$75.41M-$53.28M$3.28B$270.51M7 Day Performance6.47%0.31%0.22%2.15%1 Month Performance114.00%4.58%4.61%6.35%1 Year Performance-42.01%9.24%68.33%25.48% Shattuck Labs Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)STTKShattuck Labs3.9049 of 5 stars$2.14+19.6%$4.00+86.9%-53.0%$85.75M$5.72M-1.77100Analyst UpgradeShort Interest ↓SCPHscPharmaceuticals4.4773 of 5 stars$5.58+0.2%$7.78+39.5%+2.2%$296.87M$36.33M-3.0830Positive NewsShort Interest ↓GALTGalectin Therapeutics1.8252 of 5 stars$4.67+1.5%$6.00+28.5%+56.8%$294.68MN/A-7.309News CoverageTVRDTvardi Therapeutics2.7132 of 5 stars$29.66-4.7%$64.25+116.6%N/A$291.73M$7.14M0.0080NGNENeurogene1.7128 of 5 stars$19.45-2.5%$46.17+137.4%-58.4%$284.73M$930K-4.5190Positive NewsLFCRLifecore Biomedical0.7728 of 5 stars$7.29-3.2%$8.00+9.7%+48.3%$281.68M$128.87M-5.56690MREOMereo BioPharma Group2.3465 of 5 stars$1.79+1.1%$7.40+313.4%-58.9%$281.43M$10M-25.5740Positive NewsACBAurora Cannabis0.3975 of 5 stars$4.84-1.4%N/A-14.3%$277.19M$246.72M-25.471,130News CoverageRNACCartesian Therapeutics2.2851 of 5 stars$10.19-4.2%$40.00+292.5%-41.6%$276.66M$38.91M-0.1964Positive NewsCADLCandel Therapeutics2.4687 of 5 stars$5.10+2.0%$20.00+292.2%-30.8%$274.48M$120K-7.3960MNPRMonopar Therapeutics3.2826 of 5 stars$41.48-6.2%$69.57+67.7%+1,311.7%$272.77MN/A-12.4610News CoverageAnalyst ForecastGap Up Related Companies and Tools Related Companies scPharmaceuticals Competitors Galectin Therapeutics Competitors Tvardi Therapeutics Competitors Neurogene Competitors Lifecore Biomedical Competitors Mereo BioPharma Group Competitors Aurora Cannabis Competitors Cartesian Therapeutics Competitors Candel Therapeutics Competitors Monopar Therapeutics Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:STTK) was last updated on 9/16/2025 by MarketBeat.com Staff From Our PartnersWhy More Investors Are Using Family Trusts to Protect Their WealthFor many investors, a family trust can be an essential tool for protecting assets, avoiding probate, and ensur...SmartAsset | SponsoredCrypto Gets Official Government Backing—Here's the WinnerTrump Just Signed the GENIUS Act—One Coin is About to Explode We're at the BEGINNING of smart money really ...Crypto 101 Media | SponsoredNvidia Times 1,000,000Nvidia’s latest AI chip is a $25,000 powerhouse — with 80 billion transistors and the ability to perform 60 tr...Paradigm Press | SponsoredOpenAI’s new $300 billion dealOpenAI just signed a $300 billion cloud deal with Oracle to secure the computing power needed for its next Cha...Porter & Company | SponsoredNvidia CEO Makes First Ever Tesla AnnouncementWhile headlines focus on Tesla’s car sales, tech analyst Jeff Brown says the real story is Tesla’s role in a $...Brownstone Research | SponsoredClaim Your Share of $5.39 BILLION in AI Equity ChecksThe U.S. government just took advantage of Public Law 81-774 to crack down on AI companies... In turn, enfo...Angel Publishing | SponsoredForget AI Stocks — This Device Will REPLACE the MicrochipWhile everyone's chasing the same AI plays, George Gilder is focused on something completely different. He ...Banyan Hill Publishing | SponsoredCollege grad makes $64,000 a monthA Wall Street legend just helped train our own proprietary AI system in the stock market (a project that took ...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Shattuck Labs, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Shattuck Labs With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free STTK Stock Alerts